These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21737846)

  • 1. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease.
    Sas DJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2062-8. PubMed ID: 21737846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ambient temperature, humidity and season of year on urine composition in patients with nephrolithiasis.
    Eisner BH; Sheth S; Herrick B; Pais VM; Sawyer M; Miller N; Hurd KJ; Humphreys MR
    BJU Int; 2012 Dec; 110(11 Pt C):E1014-7. PubMed ID: 22578009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends of acute nephrolithiasis in Auckland, New Zealand.
    Du J; Johnston R; Rice M
    N Z Med J; 2009 Jul; 122(1299):13-20. PubMed ID: 19684642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stone forming risk factors in patients with type Ia glycogen storage disease.
    Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
    J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of urinary parameters as risk factors for nephrolithiasis in children with celiac disease.
    Saccomani MD; Pizzini C; Piacentini GL; Boner AL; Peroni DG
    J Urol; 2012 Aug; 188(2):566-70. PubMed ID: 22704115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
    Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
    Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    J Urol; 2009 Nov; 182(5):2330-3. PubMed ID: 19758639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National multi-institutional cooperative on urolithiasis in children: Age is a significant predictor of urine abnormalities.
    Cambareri GM; Kovacevic L; Bayne AP; Giel D; Corbett S; Schurtz E; Sukhu T; Chiang G
    J Pediatr Urol; 2015 Aug; 11(4):218-23. PubMed ID: 26119451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with primary hyperparathyroidism--why do some form stones?
    Berger AD; Wu W; Eisner BH; Cooperberg MR; Duh QY; Stoller ML
    J Urol; 2009 May; 181(5):2141-5. PubMed ID: 19296981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis and calcium oxalate nephrolithiasis.
    Chidekel AS; Dolan TF
    Yale J Biol Med; 1996; 69(4):317-21. PubMed ID: 9273985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With the Lower Prevalence of Nephrolithiasis in Children Compared With Adults.
    Grases F; Rodriguez A; Costa-Bauza A; Saez-Torres C; Rodrigo D; Gómez C; Mir-Perello C; Frontera G
    Urology; 2015 Sep; 86(3):587-92. PubMed ID: 26144339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic differences in relative risk of idiopathic calcium nephrolithiasis in North America.
    Mente A; Honey RJ; McLaughlin JR; Bull SB; Logan AG
    J Urol; 2007 Nov; 178(5):1992-7; discussion 1997. PubMed ID: 17869305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Trends, Evaluation, and Management of Pediatric Nephrolithiasis.
    Hernandez JD; Ellison JS; Lendvay TS
    JAMA Pediatr; 2015 Oct; 169(10):964-70. PubMed ID: 26302045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the medical management of stone disease.
    Tracy CR; Pearle MS
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
    Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers.
    Bergsland KJ; Kelly JK; Coe BJ; Coe FL
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F530-6. PubMed ID: 16622176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral hypercalciuria: a stealth culprit in recurrent ipsilateral urolithiasis in children.
    Tasian GE; Ziemba J; Casale P
    J Urol; 2012 Dec; 188(6):2330-5. PubMed ID: 23088966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxalate intake and the risk for nephrolithiasis.
    Taylor EN; Curhan GC
    J Am Soc Nephrol; 2007 Jul; 18(7):2198-204. PubMed ID: 17538185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.